Clinical Trials Browser

Phase 3 × Has results × Dapsone × Clear all

NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Phase 3 Completed

11 enrolled 7 charts

Gastrointestinal

Exanthema, Colorectal Neoplasms